- Home
- IKT vs SSSS Comparison
IKT vs SSSS Comparison
Compare IKT & SSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- SSSS
- Stock Information
- Founded
- IKT 2008
- SSSS 2010
- Country
- IKT United States
- SSSS United States
- Employees
- IKT N/A
- SSSS N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- SSSS Finance: Consumer Services
- Sector
- IKT Health Care
- SSSS Finance
- Exchange
- IKT Nasdaq
- SSSS Nasdaq
- Market Cap
- IKT 140.5M
- SSSS 138.2M
- IPO Year
- IKT 2020
- SSSS N/A
- Fundamental
- Price
- IKT $1.94
- SSSS $8.39
- Analyst Decision
- IKT Buy
- SSSS Strong Buy
- Analyst Count
- IKT 2
- SSSS 3
- Target Price
- IKT $8.00
- SSSS $9.33
- AVG Volume (30 Days)
- IKT 529.3K
- SSSS 260.3K
- Earning Date
- IKT 08-13-2025
- SSSS 08-06-2025
- Dividend Yield
- IKT N/A
- SSSS 60.91%
- EPS Growth
- IKT N/A
- SSSS N/A
- EPS
- IKT N/A
- SSSS N/A
- Revenue
- IKT N/A
- SSSS $3,644,430.00
- Revenue This Year
- IKT N/A
- SSSS $5,400.03
- Revenue Next Year
- IKT N/A
- SSSS N/A
- P/E Ratio
- IKT N/A
- SSSS N/A
- Revenue Growth
- IKT N/A
- SSSS N/A
- 52 Week Low
- IKT $1.12
- SSSS $3.52
- 52 Week High
- IKT $4.20
- SSSS $8.77
- Technical
- Relative Strength Index (RSI)
- IKT 52.68
- SSSS 67.40
- Support Level
- IKT $1.81
- SSSS $8.31
- Resistance Level
- IKT $2.09
- SSSS $8.35
- Average True Range (ATR)
- IKT 0.14
- SSSS 0.36
- MACD
- IKT 0.02
- SSSS -0.02
- Stochastic Oscillator
- IKT 71.70
- SSSS 73.42
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.